蚌埠医学院学报
蚌埠醫學院學報
방부의학원학보
ACTA ACADEMIAE MEDICINAE BENGBU
2014年
12期
1668-1670
,共3页
心脏病%吸入性麻醉%非心脏手术%心肌保护
心髒病%吸入性痳醉%非心髒手術%心肌保護
심장병%흡입성마취%비심장수술%심기보호
heart disease%inhalation anesthesia%non-cardiac surgery%myocardial protection
目的::探讨吸入性麻醉药在缺血性心脏病患者非心脏手术中对心肌的保护作用。方法:选取缺血性心脏病且需其他部位手术的患者96例,随机分为2组,各48例,其中对照组采用静脉麻醉的方式,治疗组采用吸入性麻醉的方式,比较吸入性麻醉药物和静脉麻醉药物对围手术期心脏事件和术后心肌缺血事件的影响,观察不同麻醉方式对患者血清肌钙蛋白Ⅰ水平的影响。结果:治疗组患者术中低血压发生率31.25%,低氧血症6.25%,使用心血管活性药物37.50%;对照组术中低血压发生率43.75%,低氧血症14.58%,使用心血管活性药物64.58%,2组术中低血压和低氧血症发生率差异均无统计学意义( P>0.05),而治疗组患者心血管活性药物使用率明显低于对照组(P<0.01);治疗组术后1、2、3 d 肌钙蛋白Ⅰ浓度异常情况发生率与对照组差异均无统计学意义(P>0.05);治疗组患者在术后即刻、术后第1天和第2天心肌缺血事件的发生率与对照组差异均无统计学意义(P>0.05)。结论:应用吸入性麻醉药物可以降低患者术中心血管药物使用,吸入性麻醉药物对冠状动脉硬化性心脏病患者接受中危非心脏手术时具有一定的心肌保护作用,可以作为老年冠心病患者的麻醉策略优化选择。
目的::探討吸入性痳醉藥在缺血性心髒病患者非心髒手術中對心肌的保護作用。方法:選取缺血性心髒病且需其他部位手術的患者96例,隨機分為2組,各48例,其中對照組採用靜脈痳醉的方式,治療組採用吸入性痳醉的方式,比較吸入性痳醉藥物和靜脈痳醉藥物對圍手術期心髒事件和術後心肌缺血事件的影響,觀察不同痳醉方式對患者血清肌鈣蛋白Ⅰ水平的影響。結果:治療組患者術中低血壓髮生率31.25%,低氧血癥6.25%,使用心血管活性藥物37.50%;對照組術中低血壓髮生率43.75%,低氧血癥14.58%,使用心血管活性藥物64.58%,2組術中低血壓和低氧血癥髮生率差異均無統計學意義( P>0.05),而治療組患者心血管活性藥物使用率明顯低于對照組(P<0.01);治療組術後1、2、3 d 肌鈣蛋白Ⅰ濃度異常情況髮生率與對照組差異均無統計學意義(P>0.05);治療組患者在術後即刻、術後第1天和第2天心肌缺血事件的髮生率與對照組差異均無統計學意義(P>0.05)。結論:應用吸入性痳醉藥物可以降低患者術中心血管藥物使用,吸入性痳醉藥物對冠狀動脈硬化性心髒病患者接受中危非心髒手術時具有一定的心肌保護作用,可以作為老年冠心病患者的痳醉策略優化選擇。
목적::탐토흡입성마취약재결혈성심장병환자비심장수술중대심기적보호작용。방법:선취결혈성심장병차수기타부위수술적환자96례,수궤분위2조,각48례,기중대조조채용정맥마취적방식,치료조채용흡입성마취적방식,비교흡입성마취약물화정맥마취약물대위수술기심장사건화술후심기결혈사건적영향,관찰불동마취방식대환자혈청기개단백Ⅰ수평적영향。결과:치료조환자술중저혈압발생솔31.25%,저양혈증6.25%,사용심혈관활성약물37.50%;대조조술중저혈압발생솔43.75%,저양혈증14.58%,사용심혈관활성약물64.58%,2조술중저혈압화저양혈증발생솔차이균무통계학의의( P>0.05),이치료조환자심혈관활성약물사용솔명현저우대조조(P<0.01);치료조술후1、2、3 d 기개단백Ⅰ농도이상정황발생솔여대조조차이균무통계학의의(P>0.05);치료조환자재술후즉각、술후제1천화제2천심기결혈사건적발생솔여대조조차이균무통계학의의(P>0.05)。결론:응용흡입성마취약물가이강저환자술중심혈관약물사용,흡입성마취약물대관상동맥경화성심장병환자접수중위비심장수술시구유일정적심기보호작용,가이작위노년관심병환자적마취책략우화선택。
Objective:To explore the protective effects of the inhaled anesthesia on myocardium in non-cardiac surgery patients with ischemic heart disease. Methods:Ninety-six patients with ischemic heart disease treated with other operation were randomly divided into the control group and treatment group ( 48 cases each group ) , treatment group were treated with control and inhaled anesthesia, respectively. The effects of whose on the perioperative cardiac event, ischemic event and level of cTnI in patients were compared. Results:The incidence rates of intraoperative hypotension, hypoxemia and using cardiovascular active drugs in treatment group and control group were 31. 25%,6. 25% and 37. 50%,and 43. 75%,14. 58% and 64. 58%,respectively,hypotension and hypoxemia had no significant difference in the incidence rate of intraoperative(P<0. 05),but unilization of cardiovascular cative drugs treatment group was significantly lower than the control group(P<0. 01). The differences of the concentration anomalies of cTnI in treatment group and control group at postoperative 1,2 and 3 days were not statistically significant(P >0. 05). The differences of the incidence rate of myocardial ischemic event in treatment group and control group after anesthesia and at postoperative 1, 2 and 3 days were not statistically significant(P>0. 05). Conclusions:The inhaled anesthesia can reduce the use of cardiovascular drugs,and protect the myocardium in non-cardiac surgery patients with ischemic heart disease, which can be used as the preferred treatment for elderly patients with coronary heart disease.